Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Absence of Multiple Sclerosis and Demyelinating Diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico.
Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.
Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions.
Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways.
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Inadvertent foley catheterization of the ureter.
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study.
Cardiovascular effects of fingolimod: A review article.
Incidence of Radiologically Isolated Syndrome: A Population-Based Study.
Reduced Myelin Water in the White Matter Tracts of Patients with Niemann-Pick Disease Type C.
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene.
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
New drug for relapsing multiple sclerosis.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.

Pages